HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.
6th Edition of Cardiology World Conference
September 15-17, 2025 | London, UK
Personalized Cardiology and Precision Medicine
Personalized Cardiology and Precision Medicine
The intersection of personalized cardiology and precision medicine offers a new frontier in the treatment of heart conditions. Through the use of genomic data, personalized cardiology allows for customized treatment plans that focus on an individual’s genetic predispositions and lifestyle factors. This level of individualized care ensures that patients receive therapies that are specifically suited to their needs, reducing the trial-and-error approach often seen in traditional medicine. By leveraging precision medicine, cardiologists can now predict how patients will respond to specific treatments, offering a more effective, proactive approach to managing cardiovascular diseases and improving patient outcomes.
Committee Members
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Gustavo Lionel Knop
Mayo Clinic, United States
Sekib Sokolovic
Sarajevo School of Science and Technology, Medical Faculty, ASA Hospital, Bosnia and Herzegowina Cardio 2025 Speakers
Arthur J Siegel
Massachusetts General Hospital, United States
Iris Panagiota Efthymiou
University of Greenwich, United Kingdom
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Y J H J Taverne
Erasmus University Medical Center, NetherlandsSubmit your abstract Today
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : Ex-situ organ perfusion and cardiac performance improvement
Y J H J Taverne, Erasmus University Medical Center, Netherlands